^Thale J, Gülker H, Hagemense B, Rose D, Haverkamp W, Frenking B (January 1987). "Electrophysiologic effects of asocainol, a new antiarrhythmic agent with predominant class I action". Arzneimittelforschung. 37 (1): 14–6.
PMID3566851.
^Thale J, Gülker H, Hagemense B, Rose D, Haverkamp W, Frenking B (January 1987). "Electrophysiologic effects of asocainol, a new antiarrhythmic agent with predominant class I action". Arzneimittelforschung. 37 (1): 14–6.
PMID3566851.